期刊文献+

沙丁胺醇联合布地奈德雾化吸入治疗老年支气管哮喘急性发作的疗效 被引量:2

Efficacy of Nebulized Salbutamol Combined with Budesonide in Treatment of Acute Attack of Asthma in Elderly Patients
暂未订购
导出
摘要 【目的】观察雾化吸入沙丁胺醇、布地奈德治疗老年轻、中度支气管哮喘急性发作期的临床疗效。[方法]60例急性发作期支气管哮喘患者随机分为观察组(30例)和对照组(30例)。观察组每天雾化吸入沙丁胺醇、布地奈德雾化混悬液。对照组仅予沙丁胺醇雾化吸入,治疗4d后观察吸入前后,临床症状、体征及肺功能的变化。【结果】观察组肺功能FEV1、PEFR、FEV1/FVC分别为(2.54±0.75)L、(4.36±0.34)、(56.96±2.42)较对照组(2.13±0.64)L、(3.67±0.32)、(28.82±1.94)明显改善,差异有显著性(P〈0.05)。两组显效率分别为86.68%、60.00%,差异有显著性(P〈0.05)。而总有效率两组分别为93.33%、83.33%,差异无显著性(P〉0.05)。【结论】沙丁胺醇联合布地奈德雾化吸入能快速缓解老年患者哮喘急性发作时的症状,控制病情,可作为治疗老年支气管哮喘急性发作的主要方法。 [Objective]To observe the clinical efficacy of nebulized salbutamol combined with budesonide in treatment of acute attack of asthma. [Methods] Sixty elderly patients with acute attack of asthma were ran domly divided into two groups. The observe group( n = 30)was treated by nebulized salbutamol combined with budesonide. The control group ( n = 30)was treated only by nebulized salbutamol. The clinical symptoms, signs and pulmonary function change after inhaling were observed. [Results]Compared with the control group, pulmonary function indexes such as FEV1, PEFR, FEV1/FVC in the observe group were improved significantly( P 〈0. 05). The effective rates of the two groups were 86. 68% and 60. 00%, respectively. There is a significant difference between them( P 〈0.05). But the total effective rates of two groups were 93. 33 % and 83.33%, respectively. [Conclusion] The atomization of salbutamol combined with budesonide can quickly ease elderly patients with acute attack of asthma symptoms, which is a convenient and effective treatment method.
作者 陈建华
出处 《医学临床研究》 CAS 2009年第3期449-450,453,共3页 Journal of Clinical Research
关键词 哮喘/药物疗法 沙丁胺醇/投药和剂量 布地奈德/投药和剂量 气雾剂 投药 吸入 asthma/DT albuterol/AD budesonide/AD aerosols administration,inhalation
  • 相关文献

参考文献9

二级参考文献24

  • 1黄丽萍,方凤.白三烯与支气管哮喘[J].国外医学(呼吸系统分册),2005,25(9):672-674. 被引量:36
  • 2蒋军广 谭伟丽 等.老年人支气管哮喘的临床特点[J].中华结核和呼吸杂志,1993,16(3):175-175.
  • 3王枢传 刘昌起.支气管哮喘的定义、诊断、诊断标准.呼吸疾病治疗学[M].天津:天津科学技术出版社,2000.505-507.
  • 4王枢传.呼吸疾病治疗[M].天津:天津科学技术出版社出版,2000.511.
  • 5Mak JC,Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta 2-adrenerjic receptor transcription in human lung. Am J Physiol, 1995,268 (1): 241 ~ 246
  • 6Baraniuk JN,Ali M,Broby D,et al. Glucocorticoids induce beta 2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med,1997,155L704~710
  • 7Eickelberg O, Roth M, Lorx R, et al. Lingand-independent activation of the glucocorticoid receptor by beta 2-adrenergic receptor agonists in primary human lung fibroblasts and vasular smooth muscle cells. J Biol Chem,1999,274:1005~1010
  • 8Bisgaard H,Nielsen KG.Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children[J].Am J RespiR Crit Care Med,2000,162(1):187-190.
  • 9Barnes NC,Smith LJ.Biochemistry and physiology of the leukotrienes[J].Clin Rey Allergy Immunol,1999,17(1-2):27-42.
  • 10Drazen JM,Israel E,O'Byrne PM.Treatment of asthma with drugs modifying the leukotriene pathway[J].N Engl J Med,1999,340(3):197-206.

共引文献3601

同被引文献18

引证文献2

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部